Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients.

<h4>Introduction</h4>The aim of this study was to determine the efficacy of early tocilizumab treatment for hospitalized patients with COVID-19 disease.<h4>Methods</h4>Open-label randomized phase II clinical trial investigating tocilizumab in patients with proven COVID-19 adm...

Full description

Bibliographic Details
Published in:PLoS ONE
Main Authors: Abraham Rutgers, Peter E Westerweel, Bronno van der Holt, Simone Postma, Marit G A van Vonderen, Djura P Piersma, Douwe Postma, Maarten van den Berge, Eefje Jong, Marten de Vries, Leonie van der Burg, Dennis Huugen, Marjolein van der Poel, Linda M Kampschreur, Marcel Nijland, Jaap H Strijbos, Menno Tamminga, Pim G N J Mutsaers, Suzanne Schol-Gelok, Margriet Dijkstra-Tiekstra, Grigory Sidorenkov, Julien Vincenten, Wouter H van Geffen, Marjolein Knoester, Jos Kosterink, Reinold Gans, Coen Stegeman, Gerwin Huls, Tom van Meerten
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Online Access:https://doi.org/10.1371/journal.pone.0271807

Internet

https://doi.org/10.1371/journal.pone.0271807

Similar Items